In our studies to identify novel genes that participate in normal hematopoiesis and leukemia, we noticed that the novel gene FAXDC2 (fatty acid hydroxylase domain containing 2) was downregulated in AML patients and increased in its expression during TPA-induced megakaryocytic differentiation of K562 cells. The gene discussed is FAXDC2; the disease is acute myeloid leukemia.